Published in J Neurol Neurosurg Psychiatry on April 01, 2000
Progressive dementia and gait disorder in a 78 year old woman. J Neurol Neurosurg Psychiatry (2000) 0.75
Diagnostic criteria for Parkinson disease. Arch Neurol (1999) 11.65
Evaluation of dementia. N Engl J Med (1996) 4.29
Creutzfeldt-Jakob disease and related transmissible spongiform encephalopathies. N Engl J Med (1998) 3.62
Gliomatosis cerebri: clinical and histological findings. Clin Neuropathol (1985) 1.33
Gliomatosis cerebri: clinical features, treatment, and prognosis. Acta Neurochir (Wien) (1998) 1.24
Abnormal diffusion-weighted magnetic resonance images in Creutzfeldt-Jakob disease. Arch Neurol (1999) 1.15
Dementia with Lewy bodies. J Am Geriatr Soc (1998) 0.98
Vascular dementia: a contemporary review of epidemiology, diagnosis, prevention, and treatment. J Am Geriatr Soc (1998) 0.97
Gliomatosis cerebri. Radiology (1996) 0.94
Epileptic seizures in elderly patients with dementia. Epilepsia (1992) 0.91
The pathophysiology of fatal familial insomnia. Brain Pathol (1998) 0.90
Magnetic resonance imaging determination of gliomatosis cerebri. Neuroradiology (1987) 0.88
Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med (2001) 6.07
Pneumocystis carinii pneumonia in the United States. Epidemiologic, diagnostic, and clinical features. Ann Intern Med (1974) 4.10
Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N Engl J Med (1995) 3.64
Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease. Neurology (2003) 3.62
Cholinergic markers in elderly patients with early signs of Alzheimer disease. JAMA (1999) 3.22
Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease. Arch Neurol (1998) 3.20
DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology (2007) 2.86
A neuronal morphologic type unique to humans and great apes. Proc Natl Acad Sci U S A (1999) 2.81
Acid sphingomyelinase deficient mice: a model of types A and B Niemann-Pick disease. Nat Genet (1995) 2.66
Alzheimer's disease: X-ray spectrometric evidence of aluminum accumulation in neurofibrillary tangle-bearing neurons. Science (1980) 2.45
Understanding cell death in Parkinson's disease. Ann Neurol (1998) 2.16
Subthalamic deep brain stimulation and impulse control in Parkinson's disease. Eur J Neurol (2009) 2.13
The evolution of diagnosis in early Parkinson disease. Parkinson Study Group. Arch Neurol (2000) 2.08
The pathology of Legionnaires' disease. Fourteen fatal cases from the 1977 outbreak in Vermont. Arch Pathol Lab Med (1978) 2.06
Rising mortality from motoneuron disease in the USA, 1962-84. Lancet (1989) 2.05
Oxidative stress and the pathogenesis of Parkinson's disease. Neurology (1996) 2.05
Failure of the ubiquitin-proteasome system in Parkinson's disease. Nat Rev Neurosci (2001) 2.04
Neurofibrillary tangles in nondemented elderly subjects and mild Alzheimer disease. Arch Neurol (1999) 2.02
Use of placebo surgery in controlled trials of a cellular-based therapy for Parkinson's disease. N Engl J Med (1999) 2.00
Pathophysiology of the basal ganglia in Parkinson's disease. Trends Neurosci (2000) 1.97
Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers. Neurology (2006) 1.89
Evidence of neuronal oxidative damage in Alzheimer's disease. Am J Pathol (1996) 1.87
MRI of brain iron. AJR Am J Roentgenol (1986) 1.76
Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease. Arch Neurol (1995) 1.69
Dissociation of neuropathology from severity of dementia in late-onset Alzheimer disease. Neurology (2006) 1.68
Intraneuronal aluminum accumulation in amyotrophic lateral sclerosis and Parkinsonism-dementia of Guam. Science (1982) 1.63
Neuropeptide abnormalities in patients with early Alzheimer disease. Arch Gen Psychiatry (1999) 1.62
A multicenter trial of ropinirole as adjunct treatment for Parkinson's disease. Ropinirole Study Group. Neurology (1998) 1.60
Manganese intoxication in the rhesus monkey: a clinical, imaging, pathologic, and biochemical study. Neurology (1996) 1.60
Multicenter study of autologous adrenal medullary transplantation to the corpus striatum in patients with advanced Parkinson's disease. N Engl J Med (1989) 1.59
Levodopa motor complications in Parkinson's disease. Trends Neurosci (2000) 1.58
Two decades of increasing mortality from Parkinson's disease among the US elderly. Arch Neurol (1990) 1.56
Investigation of a fatality from nonoccupational aluminum phosphide exposure: measurement of aluminum in tissue and body fluids as a marker of exposure. J Lab Clin Med (1993) 1.53
Neuropeptide deficits in schizophrenia vs. Alzheimer's disease cerebral cortex. Biol Psychiatry (1996) 1.52
Neurological manifestations of hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber disease): report of 2 cases and review of the literature. Ann Neurol (1978) 1.50
Accumulation of phosphorylated neurofilaments in anterior horn motoneurons of amyotrophic lateral sclerosis patients. J Neuropathol Exp Neurol (1988) 1.49
Orobuccal dyskinesia associated with trihexyphenidyl therapy in a patient with Parkinson's disease. Mov Disord (1993) 1.48
The core assessment program for intracerebral transplantation. Mov Disord (1995) 1.47
Protein nitration in Parkinson's disease. J Neuropathol Exp Neurol (1998) 1.45
Transgenic mouse model of early-onset DYT1 dystonia. Hum Mol Genet (2004) 1.42
Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits. J Neurochem (1995) 1.41
Apoptosis in neurodegenerative diseases: the role of mitochondria. Biochim Biophys Acta (1999) 1.41
Levodopa: why the controversy? Lancet (2002) 1.39
Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia: a postmortem neuropathologic study of 100 cases. Arch Gen Psychiatry (1998) 1.39
Differential distribution of neurofibrillary tangles in the cerebral cortex of dementia pugilistica and Alzheimer's disease cases. Acta Neuropathol (1992) 1.38
High-frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor. Ann Neurol (1997) 1.36
Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: a laser microprobe (LAMMA) study. Ann Neurol (1992) 1.33
Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders. Acta Neuropathol (1994) 1.26
Postmortem studies in schizophrenia. Schizophr Bull (1998) 1.23
Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease. Arch Neurol (1999) 1.22
Subthalamic nucleus-mediated excitotoxicity in Parkinson's disease: a target for neuroprotection. Ann Neurol (1998) 1.22
Stereologic analysis of neurofibrillary tangle formation in prefrontal cortex area 9 in aging and Alzheimer's disease. Neuroscience (2003) 1.22
Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Quantitative regional analysis and comparison with Alzheimer's disease. Arch Neurol (1995) 1.22
Functional fetal nigral grafts in a patient with Parkinson's disease: chemoanatomic, ultrastructural, and metabolic studies. J Comp Neurol (1996) 1.21
Pathophysiology of levodopa-induced dyskinesias in Parkinson's disease: problems with the current model. Ann Neurol (2000) 1.18
Manganese intoxication and chronic liver failure. Ann Neurol (1994) 1.18
Quantitative neuropathologic analysis of Pick's disease cases: cortical distribution of Pick bodies and coexistence with Alzheimer's disease. Acta Neuropathol (1994) 1.16
The evolution and origin of motor complications in Parkinson's disease. Neurology (2000) 1.15
Adult onset Hallervorden-Spatz disease with neurofibrillary pathology. A discrete clinicopathological entity. Brain (1987) 1.14
Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study. Brain Res (1992) 1.14
Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease. Ann Neurol (1995) 1.13
A fluorescent double-labeling method to detect and confirm apoptotic nuclei in Parkinson's disease. Ann Neurol (1998) 1.11
Reduced signal intensity on MR images of thalamus and putamen in multiple sclerosis: increased iron content? AJR Am J Roentgenol (1987) 1.11
The validity of the family history method for identifying Alzheimer disease. Arch Neurol (1997) 1.09
Myoadenylate deaminase deficiency. Functional and metabolic abnormalities associated with disruption of the purine nucleotide cycle. J Clin Invest (1984) 1.08
Stereologic assessment of the total cortical volume occupied by amyloid deposits and its relationship with cognitive status in aging and Alzheimer's disease. Neuroscience (2002) 1.08
Occupation and parkinsonism in three movement disorders clinics. Neurology (2005) 1.08
Relationship of aluminum to Alzheimer's disease. Environ Health Perspect (1985) 1.07
Immunohistochemical localization and distribution of torsinA in normal human and rat brain. Brain Res (2000) 1.07
A laser microprobe mass analysis of brain aluminum and iron in dementia pugilistica: comparison with Alzheimer's disease. Eur Neurol (1997) 1.07
Factors predictive of the need for levodopa therapy in early, untreated Parkinson's disease. The Parkinson Study Group. Arch Neurol (1995) 1.06
Multiple microabscesses in the central nervous system: a clinicopathologic study. J Neuropathol Exp Neurol (1989) 1.06
Blood manganese correlates with brain magnetic resonance imaging changes in patients with liver disease. Can J Neurol Sci (1996) 1.04
Hyperphosphorylated tau proteins differentiate corticobasal degeneration and Pick's disease. Acta Neuropathol (1996) 1.04
An immunocytochemical comparison of cytoskeletal proteins in aluminum-induced and Alzheimer-type neurofibrillary tangles. Acta Neuropathol (1986) 1.04
Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease. Mov Disord (1998) 1.03
Olfactory dysfunction in three neurodegenerative diseases. Geriatrics (1991) 1.02
Contribution of Lewy body inclusions to dementia in patients with and without Alzheimer disease neuropathological conditions. Arch Neurol (2000) 1.01
A program for neuropsychological investigation of deep brain stimulation (PNIDBS) in movement disorder patients: development, feasibility, and preliminary data. Neuropsychiatry Neuropsychol Behav Neurol (2000) 1.01
No direct correlation between serum antiacetylcholine receptor antibody levels and clinical state of individual patients with myasthenia gravis. Neurology (1981) 1.01
MRI and PET studies of manganese-intoxicated monkeys. Neurology (1995) 1.00
Cytology of human caudomedial cingulate, retrosplenial, and caudal parahippocampal cortices. J Comp Neurol (2001) 1.00
Spinal cord neurofibrillary pathology in Alzheimer disease and Guam Parkinsonism-dementia complex. J Neuropathol Exp Neurol (2001) 1.00
Fetal grafting for Parkinson's disease: expression of immune markers in two patients with functional fetal nigral implants. Cell Transplant (1997) 0.99
Alzheimer's disease and Parkinson's disease: distinct entities or extremes of a spectrum of neurodegeneration? Ann Neurol (1998) 0.99
A prospective study of thymectomy and serum acetylcholine receptor antibodies in myasthenia gravis. Ann Surg (1982) 0.99
Familial myoclonic dementia masquerading as Creutzfeldt-Jakob disease. Ann Neurol (1986) 0.98
Diencephalic amnesia: a reappraisal. J Neurol Neurosurg Psychiatry (1976) 0.97
Development of dopaminergic neurons in the human substantia nigra. Exp Neurol (1991) 0.96
Odor identification deficit of the parkinsonism-dementia complex of Guam: equivalence to that of Alzheimer's and idiopathic Parkinson's disease. Neurology (1991) 0.96
Dynamic computed tomography study of the brain. J Comput Assist Tomogr (1979) 0.95
Neuropathologic evaluation of 40 confirmed cases of Legionella pneumonia. Neurology (1983) 0.95
Neuropsychological functioning following bilateral subthalamic nucleus stimulation in Parkinson's disease. Arch Clin Neuropsychol (2004) 0.95
Clinical neuropathological conference. A 58-year-old concrete worker was amitted to the hospital because of slowly progressive dementia. Dis Nerv Syst (1974) 0.95